Physician profile
Daniel Fischer
NPI 1326422387
$1,284.94
in general payments reported to CMS, 2019-2025
14 companies · $280 in 2025
The $280 reported for 2025 was more than what 82% of Hospitalist providers received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $41.88 · 2021: $35.72 · 2022: $119 · 2023: $496 · 2024: $313 · 2025: $280.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,088.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,088.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $307.58 | 2021-2024 | Olumiant, Taltz |
| Janssen Biotech, INC. | $228.29 | 2023-2024 | Tremfya |
| Abbvie INC. | $146.40 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $144.02 | 2023-2025 | Sotyktu |
| Incyte Corporation | $98.29 | 2023 | |
| Janssen Scientific Affairs, LLC | $96.66 | 2022 | |
| Novartis Pharmaceuticals Corporation | $86.58 | 2025 | |
| Genzyme Corporation | $37.24 | 2024 | |
| Ucb, INC. | $35.19 | 2024 | Bimzelx |
| Pfizer INC. | $27.76 | 2025 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $22.91 | 2019 | |
| Dermavant Sciences, INC. | $20.44 | 2024 | Vtama |
| Leo Pharma INC. | $18.97 | 2019 | |
| Sun Pharmaceutical Industries INC. | $14.61 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Fischer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.